These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 20102506

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Comparative effect of carperitide and furosemide on left atrial pressure in dogs with experimentally induced mitral valve regurgitation.
    Suzuki S, Fukushima R, Yamamoto Y, Ishikawa T, Hamabe L, Kim S, Yoshiyuki R, Fukayama T, Machida N, Tanaka R.
    J Vet Intern Med; 2013; 27(5):1097-104. PubMed ID: 23952288
    [Abstract] [Full Text] [Related]

  • 45. A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease.
    Newhard DK, Jung S, Winter RL, Duran SH.
    J Vet Intern Med; 2018 Sep; 32(5):1555-1563. PubMed ID: 30084228
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
    Eriksson AS, Häggström J, Pedersen HD, Hansson K, Järvinen AK, Haukka J, Kvart C.
    J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
    [Abstract] [Full Text] [Related]

  • 49. A QUEST begins.
    Oyama MA.
    J Vet Intern Med; 2008 Sep; 22(5):1076-8. PubMed ID: 18844829
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases.
    Martin MW, Stafford Johnson MJ, Strehlau G, King JN.
    J Small Anim Pract; 2010 Aug; 51(8):428-36. PubMed ID: 20670255
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The effect of angiotensin-converting enzyme inhibitors of left atrial pressure in dogs with mitral valve regurgitation.
    Ishikawa T, Tanaka R, Suzuki S, Miyaishi Y, Akagi H, Iino Y, Fukushima R, Yamane Y.
    J Vet Intern Med; 2010 Aug; 24(2):342-7. PubMed ID: 20102507
    [Abstract] [Full Text] [Related]

  • 57. Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases.
    de Andrade JN, Christopher Orton E, Boon J, Nishimori CT, Olivaes C, Camacho AA.
    J Vet Cardiol; 2011 Sep; 13(3):197-201. PubMed ID: 21824833
    [Abstract] [Full Text] [Related]

  • 58. Effects of 4 classes of cardiovascular drugs on ventricular function in dogs with mitral regurgitation.
    Nakayama T, Nishijima Y, Miyamoto M, Hamlin RL.
    J Vet Intern Med; 2007 Sep; 21(3):445-50. PubMed ID: 17552449
    [Abstract] [Full Text] [Related]

  • 59. Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation.
    Moesgaard SG, Pedersen LG, Teerlink T, Häggström J, Pedersen HD.
    J Vet Intern Med; 2005 Sep; 19(5):712-9. PubMed ID: 16231716
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.